Profil
Jeffrey Paley founded Access Medical Associates LLC in 2003.
Dr. Paley also founded Crimson Biomedical Consulting, where he worked as Chief Executive Officer.
Dr. Paley also currently works at Immune Pharmaceuticals, Inc., as Independent Director from 2016 and Remote Radiology, Inc., as Director.
Dr. Paley also formerly worked at KellBenx, Inc., as Director, Travere Therapeutics, Inc., as Director from 2013 to 2014, Kalytera Therapeutics, Inc., as Director, Avenue Therapeutics, Inc., as Independent Director from 2015 to 2019, Claritas Pharmaceuticals, Inc., as Independent Director, Weill Cornell Internal Medicine Associates, as Director-Clinical Research, Journey Medical Corp., as Independent Director, and Caelum Biosciences, Inc., as Director.
Dr. Paley received his undergraduate degree from Yeshiva University and doctorate degree from Harvard Medical School.
Postes actifs de Jeff Paley
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNE PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 23/02/2016 |
Crimson Biomedical Consulting | Directeur Général | - |
Remote Radiology, Inc. | Directeur/Membre du Conseil | - |
Anciens postes connus de Jeff Paley
| Sociétés | Poste | Fin |
|---|---|---|
| JOURNEY MEDICAL CORPORATION | Directeur/Membre du Conseil | 07/12/2023 |
| AVENUE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 05/04/2019 |
| TRAVERE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 10/09/2014 |
Caelum Biosciences, Inc.
Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders | Directeur/Membre du Conseil | - |
Weill Cornell Internal Medicine Associates
Weill Cornell Internal Medicine Associates Hospital/Nursing ManagementHealth Services Operates as an hospital | Corporate Officer/Principal | - |
Formation de Jeff Paley
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
KellBenx, Inc.
KellBenx, Inc. Medical SpecialtiesHealth Technology Develops non-invasive prenatal diagnosis of genetic and inherited disorders | Health Technology |
Yeshiva University
Yeshiva University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products for the treatment of cancer and pain | Health Technology |
Travere Therapeutics, Inc.
Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Crimson Biomedical Consulting | |
Kalytera Therapeutics, Inc. /Old/
Kalytera Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Develops non-psychoactive cannabinoid medicines | Health Technology |
Avenue Therapeutics, Inc.
Avenue Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases | Health Technology |
Claritas Pharmaceuticals, Inc.
Claritas Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops and commercializes therapies for patients | Health Technology |
Access Medical Associates LLC | |
Weill Cornell Internal Medicine Associates
Weill Cornell Internal Medicine Associates Hospital/Nursing ManagementHealth Services Operates as an hospital | Health Services |
Journey Medical Corp.
Journey Medical Corp. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for the treatment of dermatological treatment conditions | Health Technology |
Caelum Biosciences, Inc.
Caelum Biosciences, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company that develops treatments for AL amyloidosis, rare and life-threatening hematologic disorders | Health Technology |
Remote Radiology, Inc. |
















